The Sony CRE-C20 is a mid-priced OTC hearing aid ($999) that earned a B grade in HearAdvisor's lab testing, ranking in the top 36% of OTC devices. This invisible-in-ear style device offers a discreet form factor with rechargeable batteries, though its compact design comes with notable trade-offs.
In our lab testing, the CRE-C20 demonstrated strong speech clarity performance. Speech in quiet and speech in noise scores both measured well above category averages, suggesting effective amplification for conversational listening. Own-voice comfort also tested above average, indicating reasonable occlusion management for an in-ear device.
However, the CRE-C20 has significant limitations. It does not support Bluetooth audio streaming, which is increasingly standard even among lower-priced OTC alternatives. Feedback handling scored below the category average, which may require more careful fit attention. The device showed substantial improvement with tuning—the fit score increased by over a full point—suggesting users may benefit from taking time to optimize settings rather than relying solely on the out-of-box configuration.
At $999, the CRE-C20 faces stiff competition. Sony's own CRE-E10 earned a top score at the same price point, while alternatives like the Apple AirPods Pro 2 offer similar sound performance at $249 with streaming capabilities. The CRE-C20 may suit users prioritizing an invisible form factor and speech clarity over streaming features, but value-conscious buyers should explore alternatives.
